Global Risk Assessment to Guide Blood Pressure Management in Cardiovascular Disease Prevention.
作者信息
Karmali Kunal N, Lloyd-Jones Donald M
机构信息
From the Department of Medicine, Division of Cardiology (K.N.K, D.M.L.-J.), Center for Primary Care Innovation, Institute of Public Health and Medicine (K.N.K.), and Department of Preventive Medicine (D.M.L.-J.), Northwestern University Feinberg School of Medicine, Chicago, IL.
出版信息
Hypertension. 2017 Mar;69(3):e2-e9. doi: 10.1161/HYPERTENSIONAHA.116.08249. Epub 2017 Jan 23.
Abstract
摘要
相似文献
1
Global Risk Assessment to Guide Blood Pressure Management in Cardiovascular Disease Prevention.全球风险评估以指导心血管疾病预防中的血压管理。
Hypertension. 2017 Mar;69(3):e2-e9. doi: 10.1161/HYPERTENSIONAHA.116.08249. Epub 2017 Jan 23.
2
Role of home blood pressure and ambulatory blood pressure monitoring in decisions of when and whom to treat: recommendations for practicing clinicians.家庭血压和动态血压监测在决定何时治疗及治疗对象方面的作用：给临床执业医生的建议
J Cardiometab Syndr. 2006 Summer;1(3):222-4. doi: 10.1111/j.1559-4564.2006.05528.x.
3
Emerging Concepts in the Diagnosis and Treatment of Hypertension in the SPRINT Era.SPRINT时代高血压诊断与治疗的新观念
Methodist Debakey Cardiovasc J. 2015 Oct-Dec;11(4):204-5. doi: 10.14797/mdcj-11-4-204.
4
Jnc 7.5.美国国立卫生研究院第七次全国高血压防治联合委员会第七次报告（Jnc 7）修订版（Jnc 7.5） （备注：这里的“Jnc 7.5”可能不是一个标准通用术语，结合语境推测可能是上述含义，具体需根据更详细背景确定准确翻译，此翻译仅供参考）
J Clin Hypertens (Greenwich). 2007 Nov;9(11):901-4. doi: 10.1111/j.1524-6175.2007.06303.x.
5
Some thoughts about recent hypertension trials.关于近期高血压试验的一些思考。
Clin Cardiol. 2007 Jun;30(6):268-70. doi: 10.1002/clc.20152.
6
New Clinical Practice Guideline for the Management of High Blood Pressure in Children and Adolescents.《儿童和青少年高血压管理新临床实践指南》
Hypertension. 2017 Oct;70(4):683-686. doi: 10.1161/HYPERTENSIONAHA.117.10050. Epub 2017 Aug 21.
7
Cardiovascular and coronary risk estimation in hypertension management.高血压管理中的心血管及冠状动脉风险评估
Heart. 2002 Sep;88(3):306-12. doi: 10.1136/heart.88.3.306.
8
Differential Approaches are Much Needed for "Real World" Management of Hypertension in the Era of "Hypertension Paradox".在“高血压悖论”时代，“真实世界”的高血压管理急需差异化方法。
Curr Hypertens Rev. 2018;14(1):2-5. doi: 10.2174/157340211401180611103932.
9
Non-dipping status in arterial hypertension: an overview.非杓型高血压状态：概述。
Curr Vasc Pharmacol. 2014 May;12(3):527-36. doi: 10.2174/157016111203140518173019.
10
PREFACE: "The Lower the Better" Association between White-coat Effect-excluded Blood Pressure and Cardiovascular Events in High-risk Hypertension: Insights from SPRINT.前言：高危高血压患者中排除白大衣效应的血压与心血管事件之间的“越低越好”关联：来自收缩压干预试验（SPRINT）的见解
Curr Hypertens Rev. 2016;12(1):2-10. doi: 10.2174/157340211201160304173629.
引用本文的文献
1
Comparison of Patients Classified as High-Risk between International Cardiovascular Disease Primary Prevention Guidelines.国际心血管疾病一级预防指南中高危患者分类的比较
J Clin Med. 2024 Jul 26;13(15):4379. doi: 10.3390/jcm13154379.
2
Individualized prevention of proton pump inhibitor related adverse events by risk stratification.通过风险分层对质子泵抑制剂相关不良事件进行个体化预防。
Nat Commun. 2024 Apr 27;15(1):3591. doi: 10.1038/s41467-024-48007-8.
3
Association Between Alcohol Consumption and Blood Pressure Levels Among HIV Sero-Positive and Sero-Negative Cohorts: A Secondary Analysis of the Vukuzazzi Study.艾滋病毒血清阳性和血清阴性队列中饮酒与血压水平之间的关联：Vukuzazzi 研究的二次分析。
J Prim Care Community Health. 2024 Jan-Dec;15:21501319241235594. doi: 10.1177/21501319241235594.
4
Estimated Population Health Benefits of Intensive Systolic Blood Pressure Treatment Among SPRINT-Eligible US Adults.SPRINT 资格美国成年人强化收缩压治疗的预估人群健康获益。
Am J Hypertens. 2023 Aug 5;36(9):498-508. doi: 10.1093/ajh/hpad047.
5
Effects of lifestyle interventions on cardiovascular risk factors in South Asians: a systematic review and meta-analysis.生活方式干预对南亚人心血管危险因素的影响：系统评价和荟萃分析。
BMJ Open. 2022 Dec 9;12(12):e059666. doi: 10.1136/bmjopen-2021-059666.
6
Effect of Sequential Nephron Blockade versus Dual Renin-Angiotensin System Blockade Plus Bisoprolol in the Treatment of Resistant Hypertension, a Randomized Controlled Trial (Resistant Hypertension on Treatment - ResHypOT).序贯肾单位阻滞与双肾素-血管紧张素系统阻断加比索洛尔治疗耐药性高血压的随机对照试验（治疗耐药性高血压 - ResHypOT）。
Vasc Health Risk Manag. 2022 Dec 15;18:867-878. doi: 10.2147/VHRM.S383007. eCollection 2022.
7
Machine learning outperforms traditional logistic regression and offers new possibilities for cardiovascular risk prediction: A study involving 143,043 Chinese patients with hypertension.机器学习在心血管风险预测方面优于传统逻辑回归，并为其提供了新的可能性：一项涉及143,043名中国高血压患者的研究。
Front Cardiovasc Med. 2022 Nov 14;9:1025705. doi: 10.3389/fcvm.2022.1025705. eCollection 2022.
8
Predicted cardiovascular disease risk and prescribing of antihypertensive therapy among patients with hypertension in Australia using MedicineInsight.使用 MedicineInsight 预测澳大利亚高血压患者的心血管疾病风险和降压治疗处方。
J Hum Hypertens. 2023 May;37(5):370-378. doi: 10.1038/s41371-022-00691-z. Epub 2022 May 2.
9
Prior Cardiovascular Treatments-A Key Characteristic in Determining Medication Adherence After an Acute Myocardial Infarction.既往心血管治疗——急性心肌梗死后决定药物依从性的关键特征。
Front Pharmacol. 2022 Mar 7;13:834898. doi: 10.3389/fphar.2022.834898. eCollection 2022.
10
Regular use of proton-pump inhibitors and risk of stroke: a population-based cohort study and meta-analysis of randomized-controlled trials.质子泵抑制剂的常规使用与中风风险：基于人群的队列研究和随机对照试验的荟萃分析。
BMC Med. 2021 Dec 3;19(1):316. doi: 10.1186/s12916-021-02180-5.
本文引用的文献
1
2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts)Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR).2016年欧洲临床实践心血管疾病预防指南：欧洲心脏病学会和其他学会关于临床实践心血管疾病预防的第六联合工作组（由10个学会的代表和特邀专家组成）由欧洲心血管预防与康复协会（EACPR）特别贡献制定。
Eur Heart J. 2016 Aug 1;37(29):2315-2381. doi: 10.1093/eurheartj/ehw106. Epub 2016 May 23.
2
Aspirin Use for the Primary Prevention of Cardiovascular Disease and Colorectal Cancer: U.S. Preventive Services Task Force Recommendation Statement.阿司匹林用于心血管疾病和结直肠癌的一级预防：美国预防服务工作组推荐声明。
Ann Intern Med. 2016 Jun 21;164(12):836-45. doi: 10.7326/M16-0577. Epub 2016 Apr 12.
3
Blood-Pressure Lowering in Intermediate-Risk Persons without Cardiovascular Disease.心血管疾病风险中等的人群的血压降低。
N Engl J Med. 2016 May 26;374(21):2009-20. doi: 10.1056/NEJMoa1600175. Epub 2016 Apr 2.
4
Alternative Strategies to Achieve Cardiovascular Mortality Goals in China and India: A Microsimulation of Target- Versus Risk-Based Blood Pressure Treatment.在中国和印度实现心血管疾病死亡率目标的替代策略：基于目标与风险的血压治疗的微观模拟
Circulation. 2016 Mar 1;133(9):840-8. doi: 10.1161/CIRCULATIONAHA.115.019985. Epub 2016 Jan 13.
5
Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis.降压预防心血管疾病和死亡：系统评价和荟萃分析。
Lancet. 2016 Mar 5;387(10022):957-967. doi: 10.1016/S0140-6736(15)01225-8. Epub 2015 Dec 24.
6
A Randomized Trial of Intensive versus Standard Blood-Pressure Control.强化与标准血压控制的随机试验
N Engl J Med. 2015 Nov 26;373(22):2103-16. doi: 10.1056/NEJMoa1511939. Epub 2015 Nov 9.
7
Can Antihypertensive Treatment Restore the Risk of Cardiovascular Disease to Ideal Levels?: The Coronary Artery Risk Development in Young Adults (CARDIA) Study and the Multi-Ethnic Study of Atherosclerosis (MESA).降压治疗能否将心血管疾病风险恢复至理想水平？：青年动脉粥样硬化风险发展研究（CARDIA研究）与多族裔动脉粥样硬化研究（MESA研究）
J Am Heart Assoc. 2015 Sep 21;4(9):e002275. doi: 10.1161/JAHA.115.002275.
8
Identifying Individuals at Risk for Cardiovascular Events Across the Spectrum of Blood Pressure Levels.识别不同血压水平范围内心血管事件的风险个体。
J Am Heart Assoc. 2015 Sep 21;4(9):e002126. doi: 10.1161/JAHA.115.002126.
9
Cost-effectiveness of 10-Year Risk Thresholds for Initiation of Statin Therapy for Primary Prevention of Cardiovascular Disease.用于心血管疾病一级预防的他汀类药物治疗起始的10年风险阈值的成本效益
JAMA. 2015 Jul 14;314(2):142-50. doi: 10.1001/jama.2015.6822.
10
Cumulative Blood Pressure in Early Adulthood and Cardiac Dysfunction in Middle Age: The CARDIA Study.成年早期累积血压与中年心脏功能障碍：CARDIA 研究。
J Am Coll Cardiol. 2015 Jun 30;65(25):2679-87. doi: 10.1016/j.jacc.2015.04.042.
Zotero 插件